Manso Jacopo, Sharifi-Rad Javad, Zam Wissam, Tsouh Fokou Patrick Valere, Martorell Miquel, Pezzani Raffaele
Endocrinology Unit, Department of Medicine (DIMED), University of Padova, Via Ospedale 105, Padova 35128, Italy.
Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Int J Endocrinol. 2021 Sep 17;2021:5516285. doi: 10.1155/2021/5516285. eCollection 2021.
Plant natural products are a plethora of diverse and complex molecules produced by the plant secondary metabolism. Among these, many can reserve beneficial or curative properties when employed to treat human diseases. Even in cancer, they can be successfully used and indeed numerous phytochemicals exert antineoplastic activity. The most common molecules derived from plants and used in the fight against cancer are polyphenols, i.e., quercetin, genistein, resveratrol, curcumin, etc. Despite valuable data especially in preclinical models on such compounds, few of them are currently used in the medical practice. Also, in adrenocortical tumors (ACT), phytochemicals are scarcely or not at all used. This work summarizes the available research on phytochemicals used against ACT and adrenocortical cancer, a very rare disease with poor prognosis and high metastatic potential, and wants to contribute to stimulate preclinical and clinical research to find new therapeutic strategies among the overabundance of biomolecules produced by the plant kingdom.
植物天然产物是植物次生代谢产生的大量多样且复杂的分子。其中,许多在用于治疗人类疾病时可具有有益或治疗特性。即使在癌症方面,它们也能成功应用,实际上众多植物化学物质具有抗肿瘤活性。源自植物且用于抗癌斗争的最常见分子是多酚类,即槲皮素、染料木黄酮、白藜芦醇、姜黄素等。尽管关于此类化合物有宝贵的数据,尤其是在临床前模型中,但目前它们中很少用于医学实践。此外,在肾上腺皮质肿瘤(ACT)中,植物化学物质很少或根本未被使用。这项工作总结了针对ACT和肾上腺皮质癌(一种预后差且转移潜力高的非常罕见的疾病)使用植物化学物质的现有研究,并希望有助于激发临床前和临床研究,以便在植物界产生的大量生物分子中找到新的治疗策略。